References
Coleman, J. A. (2008). Familial and hereditary renal cancer syndromes. Urologic Clinics of North America, 35, 563-572.
Erlic, Z., Rybicki, L., Peczkowska, M., Golcher, H., Kann, P. H., Brauckhoff, M., … European-American Pheochromocytoma Study Group. (2009). Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clinical Cancer Research, 15, 6378-6385.
Farrell, C. J., & Plotkin, S. R. (2007). Genetic causes of brain tumors: Neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurologic Clinics, 25, 925-946.
García-Donas, J., Hernando, S., Romero, N., & Jara, C. (2011). Knowledge of hereditary renal cancer syndromes. Anti-Cancer Drugs, 22(Suppl.), S15-S20.
Jonasch, E., McCutcheon, I. E., Waguespack, S. G., Wen, S., Davis, D. W., Smith, L. A., … Matin, S. F. (2011). Pilot trial of sunitinib therapy in patients with VHL disease. Annals of Oncology, 22, 2661-2666.
Kaelin, W. G. (2007). Von Hippel-Lindau disease. Annual Review of Pathology: Mechanisms of Disease, 2, 145-173.
Knudson, A. G. (1996). Hereditary cancer: Two hits revisited. Journal of Cancer Research and Clinical Oncology, 122, 135-140.
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008). Concise handbook of familial cancer susceptibility syndromes. Journal of the National Cancer Institute. Monographs, 38, 1-93.
Meister, M., Choyke, P., Anderson, C., & Patel, U. (2009). Radiological evaluation, management, and surveillance of renal masses in von Hippel-Lindau disease. Clinical Radiology, 64, 589-600.
Morrison, P. J., Donnelly, D. E., Atkinson, A. B., & Maxwell, A. P. (2010). Advances in the genetics of familial renal cancer. Oncologist, 15, 532-538.
Nguyen, C. T., Campbell, S. C., & Novick, A. C. (2008). Choice of operation for clinically localized renal tumor. Urologic Clinics of North America, 35, 645-655.
Reed, A. B., & Parekh, D. J. (2009). Surgical management of von Hippel-Lindau disease: Urologic considerations. Surgical Oncology Clinics of North America, 18, 157-174. doi:10.1016/j.soc.2008.08.005
Shehata, B. M., Stockwell, C. A., Castellano-Sanchez, A. A., Setzer, S., Schmotzer, C. L., & Robinson, H. (2008). Von Hippel-Lindau (VHL) disease: An update on the clinico-pathologic and genetic aspects. Advances in Anatomic Pathology, 15, 165-171.
Teplick, A., Kowalski, M., Biegel, J., & Nichols, K. (2011). Educational paper: Screening in cancer predisposition syndromes: Guidelines for the general pediatrician. European Journal of Pediatrics, 170, 285-294.
Wong, W. T., & Chew, E. Y. (2008). Ocular von Hippel-Lindau disease: Clinical update and emerging treatments. Current Opinion in Ophthalmology, 19, 213-217.
Coleman, J. A. (2008). Familial and hereditary renal cancer syndromes. Urologic Clinics of North America, 35, 563-572. doi:10.1016/j.ucl.2008.07.014
García-Donas, J., Hernando, S., Romero, N., & Jara, C. (2011). Knowledge of hereditary renal cancer syndromes: A pending issue for oncologists. Anti-Cancer Drugs, 22, S15-S20. doi:10.1097/1001.cad.0000390768.0000393282.0000390765
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008). Concise handbook of familial cancer susceptibility syndromes. Journal of the National Cancer Institute. Monographs, 38, 1-93. doi:10.1093/jncimonographs/lgn001
Wilding, A., Ingham, S. L., Lalloo, F., Clancy, T., Huson, S. M., Moran, A., & Evans, D. G. (2012). Life expectancy in hereditary cancer predisposing diseases: An observational study. Journal of Medical Genetics, 49, 264-269. doi:10.1136/jmed genet-2011-100562